One way Takeda lives out its values is by striving to ensure that patients are aware of and can access the company’s clinical ...
Via well-designed AI tools and workflows, trial sponsors are aiming to unify cross-functional data ecosystems to enable a ...
In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity ...
Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...
GH001 cleared by FDA for U.S. clinical investigation, enabling U.S. subject enrollmentCompany to seek FDA alignment on global Phase 3 program replicating Phase 2b designPhase 3 initiation targeted for ...
In a new ACT video interview, Shanthi Sivendran, MD, MSCR, MBA, senior vice president for cancer care support at the American ...
Researchers compared a traditional Chinese medicine, Yueju Pill, with a standard antidepressant and found both reduced ...
Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...
Explore the challenges faced by Indian pharma in developing rare disease drugs and potential solutions for innovation and cost reduction.
Mayo Clinic researchers have developed a smartwatch-based alert system that signals parents at the earliest signs of a ...
CR-001 IND cleared by U.S. FDA; Phase 1/2 ASCEND global clinical trial to evaluate CR-001 in first-line and previously ...
UCSD and the Department of Veterans Affairs Collaboration CARLSBAD, CA, UNITED STATES, December 31, 2025 /EINPresswire.com/ — AVACEN Medical announced today that Dr. Francisco Cidral, ND, PhD’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback